Fructophilic lactic acid producing bacteria

US12257274B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12257274-B2
Application numberUS-202117521383-A
CountryUS
Kind codeB2
Filing dateNov 8, 2021
Priority dateMay 13, 2019
Publication dateMar 25, 2025
Grant dateMar 25, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention discloses a novel fructophilic lactic acid producing bacteria Bacillus coagulans strain FF-7 (MTCC 25235) and the process of isolation and characterization of the bacteria.

First claim

Opening claim text (preview).

We claim: 1. A fructophilic probiotic bacteria Bacillus coagulans MTCC 25235, isolated from honey, wherein the said bacteria is present in the form of an inoculum, freeze-dried powder, fine powder, tablet, capsule, suspension, solution, emulsion, gummy, chewable or edible foods and administered along with accepted excipients, adjuvants, bioavailability enhancers. 2. The fructophilic bacteria as in claim 1 , wherein the said bacteria are isolated from honey using a process comprising steps of: a) Mixing honey with saline in the ratio of 1:10 w/v to obtain a suspension; b) Thoroughly mixing the suspension of step a) and providing heat shock at 50-70° C. for 30 minutes for selective isolation of spores; c) Isolating the bacterial colonies by incubating 1-2 ml of the suspension from step b) in suitable culture media containing fructose for 48 hrs at 35-37° C.; d) Purifying bacterial isolates by selecting and incubating morphologically distinct colonies in a suitable media containing fructose as carbon source; e) Identifying the bacterial strain by biochemical analysis and 16S rRNA sequencing as Bacillus coagulans strain FF7 bearing accession no. MTCC 25235. 3. The method fructophilic bacteria as in claim 2 , wherein the honey is selected from the group consisting of, raw honey, filtered honey, acacia honey, alfalfa honey, aster honey, avocado honey, basswood honey, beechwood honey, blueberry honey, bluegum honey, buckwheat honey, clover honey, dandelion honey, eucalyptus honey, fireweed honey, heather honey, ironbark honey, jarrah honey, leatherwood honey, linden honey, macadamia honey, manuka honey, orangeblossom honey, pinetree honey, sourwood honey, sage honey, and tupelo honey. 4. The fructophilic bacteria as in claim 2 , wherein the culture media is selected from the group consisting of MRS (De Man, Rogosa and Sharpe agar), GYA (Glucose Yeast Extract Agar), TSB (Tryptone Soya Broth), Sporulation media and Mueller Hinton Agar. 5. The fructophilic bacteria as in claim 2 , wherein the isolated probiotic strain returns positive for biochemical tests catalase, oxidase, methyl red, voges proskauers, lactose, xylose, maltose, fructose, dextrose, galactose, raffinose, trehalose, melobiose, sucrose, arabinose, mannose, inulin, sodium gluconate, salicin, sorbitol, mannitol, arabitol, methyl glucoside, rhamnose, cellobiose, ONPG, esculin hydrolysis and negative for biochemical tests sorbose malonate utilization, citrate utilization, xylitol, methyl mannoside, melezitose, erythritol, adonitol, inositol, dulcitol, glycerol, blood hemolysis, citrate and indole. 6. The fructophilic bacteria as claim 1 , wherein the optimum pH and temperature for the growth of fructophilic bacteria is 7.5 and 40° C. respectively. 7. The probiotic bacteria as claimed in claim 1 , wherein the said fructophilic probiotic bacteria is bile tolerant, gastric acid resistance and produces lactic acid.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12257274B2 cover?
The present invention discloses a novel fructophilic lactic acid producing bacteria Bacillus coagulans strain FF-7 (MTCC 25235) and the process of isolation and characterization of the bacteria.
Who is the assignee on this patent?
Majeed Muhammed, Nagabhushanam Kalyanam, Beede Kirankumar, and 2 more
What technology area does this patent fall under?
Primary CPC classification A61K35/741. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).